Testing the Effect of KnowMAP (Knowledge Management for Renal Transplant Recipients). A Randomized Controlled Study
NCT ID: NCT04296955
Last Updated: 2025-03-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
200 participants
INTERVENTIONAL
2020-03-09
2025-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Developing a Health Literacy Intervention for Immigrant Kidney Transplant Recipients
NCT06860139
Effect of Patient Education on Kidney Recipients Knowledge, Coping and Quality of Life
NCT01184937
The Use of the Social Networking to Promote Educational and Consultative Actions Among Kidney Transplanted Adolescents.
NCT03214965
Medication Knowledge, Medication Adherence and Health Literacy in Patients Who Underwent a Kidney Transplantation.
NCT02606175
Increasing Communication About Live Donor Kidney Transplant
NCT01855438
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Through a RCT this project aims to test the effect of a new health communication intervention, KnowMAP (knowledge management for renal transplant recipients), as compared with standard care in patients undergoing renal transplantation.
KnowMap is a novel intervention designed by clinicians and researchers at Oslo University Hospital (OUS), University of Oslo (UiO) and University of Stavanger (UiS). The intervention is targeting knowledge management skills of patients by using motivational interview (MI) techniques. It represents 4 sessions of individual patient counselling starting the first week after the transplantation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
1. The intervention: 4 individual patient counseling sessions using adapted motivational interviewing techniques in addition to usual care.
2. Usual care: patients undergo standard patient education program for renal transplant recipients at OUS.
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Health communication intervention
Motivational interview as a new health communication intervention (one arm)
Motivational interview as a new health communication intervention
Same as intervention name
Standard care
Standard care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Motivational interview as a new health communication intervention
Same as intervention name
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to speak and understand Norwegian
Exclusion Criteria
* Kidney transplanted patient \<18 years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Helse Sor-Ost
OTHER_GOV
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tone Vidnes
PhD student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andersen
Role: PRINCIPAL_INVESTIGATOR
Oslo University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oslo University Hospital
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
29385
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.